3-Fluoro-N-(S)-pyrrolidin-3-yl-benzenesulfonaMide hydrochloride
|
- $425 - $680
- Product name: 3-Fluoro-N-(S)-pyrrolidin-3-yl-benzenesulfonaMide hydrochloride
- CAS: 1354018-70-4
- MF: C10H14ClFN2O2S
- MW: 280.7467632
- EINECS:
- MDL Number:MFCD21098947
- Synonyms:(S)-3-Fluoro-N-(pyrrolidin-3-yl)benzenesulfonaMide hydrochloride;3-Fluoro-N-(S)-pyrrolidin-3-yl-benzenesulfonaMide hydrochloride
4 prices
Selected condition：
Brand
- Alichem
- Apolloscientific
- Chemenu
- SynQuest Laboratories
Package
- 500mg
- 1g
- ManufacturerAlichem
- Product number1354018704
- Product description(S)-3-Fluoro-N-(pyrrolidin-3-yl)benzenesulfonamidehydrochloride
- Packaging1g
- Price$452
- Updated2021-12-16
- Buy
- ManufacturerApolloscientific
- Product numberPC408374
- Product description3-Fluoro-N-(S)-pyrrolidin-3-yl-benzenesulfonamidehydrochloride
- Packaging500mg
- Price$425
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM197469
- Product description(S)-3-Fluoro-N-(pyrrolidin-3-yl)benzenesulfonamidehydrochloride 95%
- Packaging1g
- Price$524
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H69-7-S0
- Product description3-Fluoro-N-(S)-pyrrolidin-3-yl-benzenesulfonamide hydrochloride
- Packaging500mg
- Price$680
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Alichem | 1354018704 | (S)-3-Fluoro-N-(pyrrolidin-3-yl)benzenesulfonamidehydrochloride | 1g | $452 | 2021-12-16 | Buy |
| Apolloscientific | PC408374 | 3-Fluoro-N-(S)-pyrrolidin-3-yl-benzenesulfonamidehydrochloride | 500mg | $425 | 2021-12-16 | Buy |
| Chemenu | CM197469 | (S)-3-Fluoro-N-(pyrrolidin-3-yl)benzenesulfonamidehydrochloride 95% | 1g | $524 | 2021-12-16 | Buy |
| SynQuest Laboratories | 8H69-7-S0 | 3-Fluoro-N-(S)-pyrrolidin-3-yl-benzenesulfonamide hydrochloride | 500mg | $680 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|